Paper39316111
Trans-acting genetic modifiers of clinical severity in heterozygous β-Thalassemia trait.
Loh JB and 3 others. Ann Hematol, 2024. Cited by 4 papers, by iCite.
Cite this record
ConductScience Library. Trans-acting genetic modifiers of clinical severity in heterozygous β-Thalassemia trait. Papers, record 39316111. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39316111
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| beta-Thalassemia | Major topic |
| Heterozygote | Major topic |
| Mutation | Major topic |
| Humans | |
| beta-Globins | |
| Severity of Illness Index | |
| Genes, Modifier | |
| alpha-Globins | |
| Ion Channels |
Source PubMed
References71
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 33626255 | β-Thalassemias. | N Engl J Med | 2021 | https://conductscience.org/library/papers/33626255 | PubMed |
| 2 | 15921380 | Genetic modifiers of beta-thalassemia. | Haematologica | 2005 | https://conductscience.org/library/papers/15921380 | PubMed |
| 3 | 37357829 | Epidemiology of clinically significant forms of alpha- and beta-thalassemia: A global map of evidence and gaps. | Am J Hematol | 2023 | https://conductscience.org/library/papers/37357829 | PubMed |
| 4 | 27123947 | Diverse hematological phenotypes of β-thalassemia carriers. | Ann N Y Acad Sci | 2016 | https://conductscience.org/library/papers/27123947 | PubMed |
| 5 | 29458725 | Molecular Basis and Genetic Modifiers of Thalassemia. | Hematol Oncol Clin North Am | 2018 | https://conductscience.org/library/papers/29458725 | PubMed |
| 6 | 34766559 | Molecular genetics of β-thalassemia: A narrative review. | Medicine (Baltimore) | 2021 | https://conductscience.org/library/papers/34766559 | PubMed |
| 7 | 18768527 | Controlling alpha-globin: a review of alpha-globin expression and its impact on beta-thalassemia. | Haematologica | 2008 | https://conductscience.org/library/papers/18768527 | PubMed |
| 8 | 31894534 | Alpha-hemoglobin-stabilizing protein (AHSP): a modulatory factor in β-thalassemia. | Int J Hematol | 2020 | https://conductscience.org/library/papers/31894534 | PubMed |
| 9 | 16339656 | Role of alpha-hemoglobin-stabilizing protein in normal erythropoiesis and beta-thalassemia. | Ann N Y Acad Sci | 2005 | https://conductscience.org/library/papers/16339656 | PubMed |
| 10 | 28337528 | A molecular study on the role of alpha-hemoglobin-stabilizing protein in hemoglobin H disease. | Ann Hematol | 2017 | https://conductscience.org/library/papers/28337528 | PubMed |
| 11 | 15545996 | Loss of alpha-hemoglobin-stabilizing protein impairs erythropoiesis and exacerbates beta-thalassemia. | J Clin Invest | 2004 | https://conductscience.org/library/papers/15545996 | PubMed |
| 12 | 17874450 | Population analysis of the alpha hemoglobin stabilizing protein (AHSP) gene identifies sequence variants that alter expression and function. | Am J Hematol | 2008 | https://conductscience.org/library/papers/17874450 | PubMed |
| 13 | 30558442 | The Chaperones Involved in Hemoglobin Synthesis Take the Spotlight: Analysis of AHSP in the Argentinean Population and Review of the Literature. | Hemoglobin | 2018 | https://conductscience.org/library/papers/30558442 | PubMed |
| 14 | 20627634 | Analysis of alpha-hemoglobin-stabilizing protein (AHSP) gene as a genetic modifier to the phenotype of beta-thalassemia in Southern China. | Blood Cells Mol Dis | 2010 | https://conductscience.org/library/papers/20627634 | PubMed |
| 15 | 14715623 | Evaluation of alpha hemoglobin stabilizing protein (AHSP) as a genetic modifier in patients with beta thalassemia. | Blood | 2004 | https://conductscience.org/library/papers/14715623 | PubMed |
| 16 | 31190133 | Association of alpha hemoglobin-stabilizing protein (AHSP) gene mutation and disease severity among HbE-beta thalassemia patients. | Ann Hematol | 2019 | https://conductscience.org/library/papers/31190133 | PubMed |
| 17 | 25156257 | HSP70 sequestration by free α-globin promotes ineffective erythropoiesis in β-thalassaemia. | Nature | 2014 | https://conductscience.org/library/papers/25156257 | PubMed |
| 18 | 37586368 | RNA polymerase II pausing temporally coordinates cell cycle progression and erythroid differentiation. | Dev Cell | 2023 | https://conductscience.org/library/papers/37586368 | PubMed |
| 19 | 36054783 | A stepwise haematological screening and whole-exome sequencing reveal multiple mutations from SUPT5H causing an elevation of Hb A2 from a cohort of 47336 individuals. | Int J Lab Hematol | 2023 | https://conductscience.org/library/papers/36054783 | PubMed |
| 20 | 38373659 | SUPT5H mutations associated with elevation of Hb A2 level: Identification of two novel variants and literature review. | Gene | 2024 | https://conductscience.org/library/papers/38373659 | PubMed |
Cited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42411795 | Luspatercept Induces Significant Improvement in Anemia in Dominant Thalassemia Secondary to Heterozygous STEAP3 and Beta-Thalassemia Trait. | Am J Hematol | 2026 | https://conductscience.org/library/papers/42411795 | PubMed |
| 42314035 | Delayed recognition and significant morbidity in adults with non-transfusion-dependent thalassemia. | Blood Adv | 2026 | https://conductscience.org/library/papers/42314035 | PubMed |
| 42059972 | Clinical phenotypic heterogeneity in pediatric-thalassemia carriers co-inherited with-globin gene triplication. | Ann Hematol | 2026 | https://conductscience.org/library/papers/42059972 | PubMed |
| 42055813 | Third-generation sequencing technology in the prevention and control of thalassemia: Applications and advances. | J Int Med Res | 2026 | https://conductscience.org/library/papers/42055813 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| HBA2 | 3040 | PubTator's text mining | https://conductscience.org/library/genes/3040 | NCBI Gene |
| HBB | 3043 | PubTator's text mining | https://conductscience.org/library/genes/3043 | NCBI Gene |
| PIEZO1 | 9780 | PubTator's text mining | https://conductscience.org/library/genes/9780 | NCBI Gene |
| SUPT5H | 6829 | PubTator's text mining | https://conductscience.org/library/genes/6829 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39316111
GET https://conductscience.org/api/papers/v1/39316111/references?page=2